
Natera (NTRA) Stock Forecast & Price Target
Natera (NTRA) Analyst Ratings
Bulls say
Natera is financially stable with a current ratio of 2.63 and a debt-to-equity ratio of 0.60, showing their ability to meet short-term obligations and their conservative financial structure. With a strong focus on research and development, Natera is continuously expanding its product offerings and reaching new markets, making it a promising investment for the future.
Bears say
Natera is expected to experience rapid growth in its Signatera MRD business, which, along with additional growth from its Latitude and Foresight products, is likely to have a major impact on the company's stock. However, there are concerns about increasing competition in the MRD market, particularly from other well-funded players, and persistent competitive intensity in the Women's Health market. Additionally, there are risks associated with Natera's aggressive investments in new market opportunities, such as pediatricians and newborn screening, which could potentially strain the company's financials and put pressure on its stock.
This aggregate rating is based on analysts' research of Natera and is not a guaranteed prediction by Public.com or investment advice.
Natera (NTRA) Analyst Forecast & Price Prediction
Start investing in Natera (NTRA)
Order type
Buy in
Order amount
Est. shares
0 shares